-The Hindu     Genetically modified crops, whose ecological effects are irreversible, could become a mainstay of Indian agriculture thanks to collusion between the government and the biotech industry The final report of the Supreme Court-appointed Technical Expert Committee (TEC) on field trials of genetically modified crops is packed with revelations on what is wrong with institutional governance and regulation in India when it comes to GMOs (genetically-modified organisms). The report's release late last...

-DNA With the union cabinet approving a proposal to amend the RTI Act to keep political parties out of its purview, the controversy about six national political parties having been declared "public authorities" by the CIC has taken a rather serious turn. Political parties, acting though Parliament, are on the verge of undoing a law that Parliament itself had given to the nation. The argument that the law should apply to...

-Frontline The National Advisory Council recommendations seem to be making a strong case for a major role for the private sector in the delivery of health care. THE recommendations for universal health coverage drawn up by the National Advisory Council (NAC), headed by United Progressive Alliance (UPA) chairperson Sonia Gandhi, push for public-private partnerships (PPPs) in the health delivery system but not for any inbuilt mechanisms for accountability. The NAC also...

-The Hindu Kochi: An artificial scarcity of drugs looms large with the new drug pricing regime, slashing prices for 348 essential drugs, set to prevail from July 29. Many retailers who stock medicines for a week are not picking up medicines and are keeping a minimum inventory. Some retailers said distributors were not making medicines available. It has sent medical retail stores into a tizzy about the fate of already available stocks. J.S....

-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...